Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jimmy W. Lee"'
Autor:
Amanda N. Robin, Alicia A. Farmer, Kari O'Connell, Alison K. Varty, James A. Hewlett, Jimmy W. Lee
Publikováno v:
The Bulletin of the Ecological Society of America. 103
Autor:
Laura L. Presley, Jonathan Braun, Jingxiao Ye, Neal L. Schiller, James Borneman, Jimmy W. Lee, Elizabeth Bent, Daniel S. Straus, Bo Wei
Publikováno v:
Inflammatory Bowel Diseases. 14:1041-1050
Microorganisms appear to play important yet ill-defined roles in the etiologies of Crohn's disease (CD) and ulcerative colitis (UC).1–3 CD and UC occur in regions of the intestine where enteric bacteria are found in the highest concentrations.4 Con
Autor:
Lawrence Steinman, Sawsan Youssef, Jimmy W. Lee, Michael G. Kattah, Ping Wang, Kathryn DeFea, Daniel S. Straus
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 181(9)
The IL-23/IL-17 pathway plays an important role in chronic inflammatory diseases, including inflammatory bowel disease. In inflammatory bowel disease, intestinal epithelial cells are an important source of chemokines that recruit inflammatory cells.
Autor:
Ligia Toro, Abderrahmane Alioua, Jimmy W. Lee, Daniel S. Straus, Christian Lytle, Poonam J. Bajwa
Publikováno v:
American journal of physiology. Gastrointestinal and liver physiology. 293(6)
Fibrates are peroxisome proliferator-activated receptor-α (PPARα) ligands in widespread clinical use to lower plasma triglyceride levels. We investigated the effect of fenofibrate and clofibrate on ion transport in mouse intestine and in human T84
Autor:
Charles O. Elson, Monica J. Carson, Jimmy W. Lee, Poonam J. Bajwa, Yingzi Cong, Daniel S. Straus, Christian Lytle, Daniel R. Jeske
Publikováno v:
Gastroenterology. 133(1)
Background & Aims: Interleukin-10 knockout (IL-10 −/− ) mice spontaneously develop colitis characterized by T-helper cell type 1–polarized inflammation. We tested the possible therapeutic activity of the peroxisome proliferator-activated recept
Publikováno v:
Inflammatory bowel diseases. 11(3)
Aims To test whether the peroxisome proliferator-activated receptor gamma (PPARgamma) ligand rosiglitazone (Ro) has therapeutic activity in the IL-10(-/-) mouse model of inflammatory bowel disease (IBD), and to identify the cellular targets and molec
Publikováno v:
Inflammatory Bowel Diseases; Mar2005, Vol. 11 Issue 3, p231-243, 13p